Watch Ticker

Coherus BioSciences, Inc.

Go to Coherus BioSciences, Inc. Website

$0.87

0.00 (0.00%)

Live

Previous Close

$0.868

Day Range

$0 - $0

Previous Day Range

$0.8607 - $0.9248

Market Cap

$101.8 million USD

Day Vol.

Previous Day Vol.

966090

Currency

USD

Primary Exchange

Nasdaq

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Coherus Biosciences, Inc. - Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

Coherus BioSciences announced it will repurchase $170 million of its convertible notes and divest its UDENYCA franchise to Intas Pharmaceuticals. The company plans to repurchase the remaining $60 million of convertible notes after the divestiture closes.

Related tickers: CHRS.

Read Full Article

Delveinsight - Hepatic Tumor Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain

The hepatic tumor market is driven by the increasing incidence of liver cancer, advancements in treatment options, and the growing emphasis on personalized medicine and combination therapies. The pipeline comprises 75+ companies working on 75+ pipeline therapies, with several promising candidates in different phases of clinical trials.

Related tickers: CANF, CHRS.

Read Full Article

Trending Tickers

Please sign in to view